
Abbott Leaps on Recent Stock Fluctuations
Abbott Laboratories (NYSE:ABT) CEO Robert Ford cited his company’s latest quarterly report, telling reporters that Wall Street’s reaction to the results was extreme. “I think this is a little bit of an overreaction. Of course, we are all over this,” Ford said. “We’re focused on this, but the fundamentals of the entire rest…